Latest News

The U.S. FDA Priority Review Voucher Read more

Counterfeit, Substandard and Generic Drugs: Distinct Definitions for Distinctly Different Problems Read more

Valganciclovir Patent Set Aside in India read MSF's statement

MSF hosts malnutrition symposium in NY Read more







Tuberculosis


© Daniel Jaquet

Cough Up for TB ! MSF publishes new report revealing how Europe is failing to match up to the funding needs for new medical tools to beat tuberculosis Read more

Press Release: Europe Failing to Respond to Global TB Threat

 

 

 

Reality Check on TB diagnostics MSF is holding a satellite meeting at the Union Conference in Paris to explore our and others' experience of diagnosing TB in the places where we work Read more

 

 

 


© Donald Weber


© Donald Weber

The Cambridge Declaration MSF has become a founder member of a new initiative, bringing together many actors in the field, that aims to drive forward clinical research into better treatment of drug-resistant TB.

Read more

Long, toxic and barely effective: Patients with drug resistant TB must struggle with a two year treatment course, comprised of a complex combination of toxic drugs, that often have appalling side-effects.

Click here to find out how MSF's patients in Uzbekistan cope


© Donald Weber


© Donald Weber

Matching medical needs with new funding ideas: MSF brought together experts in fields of TB diagnostics development and health economists to brainstorm new ways of stimulating development of new diagnostic tools for TB Read a report of the meeting 

 

Meet Monica Juma. She lives in Mathare, an impoverished community near Nairobi. She is co-infected with HIV and drug-resistant tuberculosis. Monica has to take care of her family while under treatment so she needs to come to the MSF clinic twice a day, everyday. Click here for slideshow


© Brendon Bannon

New Drug Trials for Drug-Resistant TB

In a series of papers published by PLoS, international experts explain how innovative trials in patients with drug resistant TB could speed up delivery of new drugs, explore how to fill up the current TB pipeline with additional promising drugs and call for building of clinical trial capacity in developing countries.

Paper on Randomized drug trials

Paper on New approaches to filling drug pipeline

Paper on Building clinical trials capacity

 

Access challenges for DR TB drugs


© Donald Weber

Getting hold of the drugs to treat our patients with drug resistant TB can be a real challenge: limited availability, irregular supplies and a lack of affordable generic drugs all increase the barriers to effective care Read more

Dying for a Test


© Brendan Bannon


Martine Usdin, biologist with the MSF Access Campaign explains what needs to be done to improve TB diagnostics now and in the future. Click here

Click here to read MSF's analysis of the TB diagnostics pipeline

 

 

MSF and Tuberculosis


© Brendon Bannon


MSF and TB

Diagnosing TB

Treating TB

Drug-Resistant TB

Co-infection with HIV

Looking for new tools

Supply challenges for DR TB drugs

Resistant Strains